By conducting integrated genomic and transcriptomic analyses of breast cancers with different molecular subtypes and clinicopathological features, we identified a subset of PHF genes, including PGYO2, CHD3, and ZMYND8, that have high frequencies of CNA and altered mRNA expression. This evidence concerns the gene ZMYND8 and breast carcinoma.